Fig. 3From: Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysisKaplan Meier analysis of treatment persistence with octreotide vs lanreotide, all patients (n = 1308). Numbers above axis indicate subjects at risk. Survival indicates probability of patients continuing treatment. LAN lanreotide; OCT octreotideBack to article page